IO Biotech’s Phase 3 melanoma vaccine Cylembia added to Merck’s Keytruda narrowly missed statistical significance, with median progression-free survival of 19.4 months versus 11 months for Keytruda alone. Fosun Pharma’s deal with Expedition Therapeutics grants rights outside Greater China to XH-S004, a first-in-class oral DPP-1 inhibitor for chronic respiratory diseases, in a pact potentially worth…
Read more
Space & Astronomy Climate & Environment Medicine & Health Physics & Materials Science Technology & Innovation Sources: This report is based on science news and press releases from Aug. 11–12, 2025 (and surrounding dates) by reputable outlets and institutions, including Nature nature.com unr.edu, Scientific American scientificamerican.com, ScienceDaily sciencedaily.com sciencedaily.com, NASA science.nasa.gov, Reuters reuters.com, Euronews/AP euronews.com, university…
Read more
Researchers in China unveiled a hydrogel-based “smart” wound dressing that speeds diabetic ulcer healing, with a single application achieving about 90% wound closure in 12 days by delivering microRNA-loaded vesicles that suppress the vessel-growth inhibitor TSP-1. A Swedish study published August 8 identified 87 DNA methylation sites in blood from 752 newly diagnosed diabetics followed…
Read more
Drug Approvals & Regulatory Developments (In Europe, regulators also made news: the EMA’s committee recommended approving darolutamide (Bayer’s Nubeqa) with hormone therapy for metastatic prostate cancer based on positive Phase 3 data onclive.com.) Clinical Trials & Research Breakthroughs Public Health & Policy Industry & Business Updates Sources: Key information and quotes in this report were…
Read more
Scientific Breakthroughs & Discoveries (Aug 7–8, 2025) Regulatory Updates (FDA and Other Agencies) Mergers, Acquisitions & Financial News Public Health & Policy Updates Sources: The information above is sourced from recent press releases, regulatory announcements, and news reports between Aug 7–8, 2025, including Scripps Research eurekalert.org eurekalert.org, EurekAlert! eurekalert.org, Boston Globe kffhealthnews.org bostonglobe.com, UC Davis Health…
Read more
The global sleep tech devices market was valued at over $21 billion in 2023 and is projected to grow rapidly. In 2024, major wearables such as the Samsung Galaxy Watch and Apple Watch gained FDA-approved sleep apnea detection capabilities. The latest Oura Ring Generation 4 includes research-grade sensors for blood oxygen and breathing disturbances to…
Read more
On July 22, 2025, NASA, with SpaceX, launched TRACERS, a twin-satellite mission aboard a Falcon 9 to study magnetic reconnection in Earth’s magnetosphere. The University of Iowa-led TRACERS mission will fly two probes through Earth’s northern magnetic cusp in tandem to improve space weather forecasts. A UK study found that vaccinating pregnant women against RSV…
Read more
On July 2, 2025, the FDA granted accelerated approval to linvoseltamab (Lynozyfic), a BCMA-targeting bispecific antibody, for adults with heavily pretreated relapsed/refractory multiple myeloma, after trials showed a 70% response rate. Also on July 2, 2025, the FDA approved sunvozertinib (Zegfrovy) as the first targeted oral therapy for advanced NSCLC with EGFR exon 20 insertion…
Read more
In April 2025, Roche’s Ventana TROP2 (EPR20043) RxDx test became the first AI-powered diagnostic to receive FDA Breakthrough Device Designation. The device pairs an immunohistochemistry stain for TROP2 with a digital pathology AI algorithm that runs in Roche’s Navify system to analyze NSCLC biopsy slides. The AI calculates a Normalized Membrane Ratio (NMR), the ratio…
Read more
3I/ATLAS, an interstellar comet, was detected on July 1, 2025, possibly 10 km across, and is the third known interstellar visitor after ʻOumuamua (2017) and Borisov (2019). <li NASA’s Parker Solar Probe captured the closest-ever images of the Sun’s corona and solar wind from 3.8 million miles away during a December 24, 2024 flyby. <li…
Read more
